RDIF and the Gamaleya Center announce International scientific advisory board on Sputnik V vaccine Russian Direct Investment Fund 426 Russian Direct Investment Fund 19 January 2021 14:54 The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund) and The National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya (Gamaleya Center) announce the creation of an International Scientific Advisory Board on the Sputnik V vaccine – the world s first registered vaccine against coronavirus. Leading scientists in virology, microbiology, genetics and biotechnology fr om Argentina, Croatia, France, Germany, India, Russia, Sweden, UK and USA, representing top research and medical centers, have joined the Board.